nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Reaction febrile—Bleomycin—testicular cancer	0.154	0.154	CcSEcCtD
Capreomycin—Ototoxicity—Cisplatin—testicular cancer	0.0471	0.0471	CcSEcCtD
Capreomycin—Nephrotoxicity—Ifosfamide—testicular cancer	0.0344	0.0344	CcSEcCtD
Capreomycin—Renal tubular necrosis—Ifosfamide—testicular cancer	0.0307	0.0307	CcSEcCtD
Capreomycin—Nephrotoxicity—Cisplatin—testicular cancer	0.0297	0.0297	CcSEcCtD
Capreomycin—Induration—Bleomycin—testicular cancer	0.0287	0.0287	CcSEcCtD
Capreomycin—Nephropathy toxic—Bleomycin—testicular cancer	0.0223	0.0223	CcSEcCtD
Capreomycin—Hypomagnesaemia—Bleomycin—testicular cancer	0.0202	0.0202	CcSEcCtD
Capreomycin—Induration—Etoposide—testicular cancer	0.0193	0.0193	CcSEcCtD
Capreomycin—Nephropathy toxic—Ifosfamide—testicular cancer	0.0191	0.0191	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—testicular cancer	0.018	0.018	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—testicular cancer	0.0167	0.0167	CcSEcCtD
Capreomycin—Nephropathy toxic—Cisplatin—testicular cancer	0.0164	0.0164	CcSEcCtD
Capreomycin—Nephropathy toxic—Etoposide—testicular cancer	0.0151	0.0151	CcSEcCtD
Capreomycin—Hypocalcaemia—Dactinomycin—testicular cancer	0.0131	0.0131	CcSEcCtD
Capreomycin—Deafness—Vinblastine—testicular cancer	0.0123	0.0123	CcSEcCtD
Capreomycin—Hypocalcaemia—Ifosfamide—testicular cancer	0.012	0.012	CcSEcCtD
Capreomycin—Abscess—Cisplatin—testicular cancer	0.0119	0.0119	CcSEcCtD
Capreomycin—Hearing impaired—Ifosfamide—testicular cancer	0.0115	0.0115	CcSEcCtD
Capreomycin—Hearing impaired—Cisplatin—testicular cancer	0.00992	0.00992	CcSEcCtD
Capreomycin—Pain—Carboplatin—testicular cancer	0.00982	0.00982	CcSEcCtD
Capreomycin—Hepatocellular injury—Cisplatin—testicular cancer	0.00944	0.00944	CcSEcCtD
Capreomycin—Body temperature increased—Carboplatin—testicular cancer	0.00908	0.00908	CcSEcCtD
Capreomycin—Deafness—Ifosfamide—testicular cancer	0.00889	0.00889	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—testicular cancer	0.00876	0.00876	CcSEcCtD
Capreomycin—Renal impairment—Ifosfamide—testicular cancer	0.00835	0.00835	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—testicular cancer	0.00825	0.00825	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—testicular cancer	0.0081	0.0081	CcSEcCtD
Capreomycin—Deafness—Cisplatin—testicular cancer	0.00766	0.00766	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—testicular cancer	0.00763	0.00763	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—testicular cancer	0.00763	0.00763	CcSEcCtD
Capreomycin—Liver disorder—Methotrexate—testicular cancer	0.0076	0.0076	CcSEcCtD
Capreomycin—Hypokalaemia—Ifosfamide—testicular cancer	0.00724	0.00724	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—testicular cancer	0.00706	0.00706	CcSEcCtD
Capreomycin—Abscess—Methotrexate—testicular cancer	0.00655	0.00655	CcSEcCtD
Capreomycin—Leukopenia—Chlorambucil—testicular cancer	0.00648	0.00648	CcSEcCtD
Capreomycin—Hypokalaemia—Cisplatin—testicular cancer	0.00624	0.00624	CcSEcCtD
Capreomycin—Abscess—Epirubicin—testicular cancer	0.00613	0.00613	CcSEcCtD
Capreomycin—Renal failure—Ifosfamide—testicular cancer	0.00602	0.00602	CcSEcCtD
Capreomycin—Vertigo—Vinblastine—testicular cancer	0.00596	0.00596	CcSEcCtD
Capreomycin—Leukopenia—Vinblastine—testicular cancer	0.00594	0.00594	CcSEcCtD
Capreomycin—Thrombocytopenia—Chlorambucil—testicular cancer	0.00578	0.00578	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—testicular cancer	0.00567	0.00567	CcSEcCtD
Capreomycin—Oliguria—Methotrexate—testicular cancer	0.00562	0.00562	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinblastine—testicular cancer	0.0053	0.0053	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—testicular cancer	0.0053	0.0053	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—testicular cancer	0.00526	0.00526	CcSEcCtD
Capreomycin—Renal failure—Cisplatin—testicular cancer	0.00519	0.00519	CcSEcCtD
Capreomycin—Tinnitus—Ifosfamide—testicular cancer	0.00513	0.00513	CcSEcCtD
Capreomycin—Pain—Chlorambucil—testicular cancer	0.00505	0.00505	CcSEcCtD
Capreomycin—Leukopenia—Bleomycin—testicular cancer	0.00501	0.00501	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—testicular cancer	0.0049	0.0049	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—testicular cancer	0.00487	0.00487	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—testicular cancer	0.00485	0.00485	CcSEcCtD
Capreomycin—Renal failure—Etoposide—testicular cancer	0.00476	0.00476	CcSEcCtD
Capreomycin—Urticaria—Chlorambucil—testicular cancer	0.00469	0.00469	CcSEcCtD
Capreomycin—Leukopenia—Dactinomycin—testicular cancer	0.00468	0.00468	CcSEcCtD
Capreomycin—Body temperature increased—Chlorambucil—testicular cancer	0.00467	0.00467	CcSEcCtD
Capreomycin—Pain—Vinblastine—testicular cancer	0.00463	0.00463	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—testicular cancer	0.00449	0.00449	CcSEcCtD
Capreomycin—Thrombocytopenia—Bleomycin—testicular cancer	0.00448	0.00448	CcSEcCtD
Capreomycin—Tinnitus—Cisplatin—testicular cancer	0.00442	0.00442	CcSEcCtD
Capreomycin—Hypersensitivity—Chlorambucil—testicular cancer	0.00435	0.00435	CcSEcCtD
Capreomycin—Vertigo—Ifosfamide—testicular cancer	0.0043	0.0043	CcSEcCtD
Capreomycin—Leukopenia—Ifosfamide—testicular cancer	0.00429	0.00429	CcSEcCtD
Capreomycin—Thrombocytopenia—Dactinomycin—testicular cancer	0.00418	0.00418	CcSEcCtD
Capreomycin—Hypersensitivity—Vinblastine—testicular cancer	0.00399	0.00399	CcSEcCtD
Capreomycin—Pain—Bleomycin—testicular cancer	0.00391	0.00391	CcSEcCtD
Capreomycin—Thrombocytopenia—Ifosfamide—testicular cancer	0.00383	0.00383	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—testicular cancer	0.0037	0.0037	CcSEcCtD
Capreomycin—Leukopenia—Cisplatin—testicular cancer	0.00369	0.00369	CcSEcCtD
Capreomycin—Pain—Dactinomycin—testicular cancer	0.00365	0.00365	CcSEcCtD
Capreomycin—Urticaria—Bleomycin—testicular cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Body temperature increased—Bleomycin—testicular cancer	0.00361	0.00361	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—testicular cancer	0.00342	0.00342	CcSEcCtD
Capreomycin—Vertigo—Etoposide—testicular cancer	0.0034	0.0034	CcSEcCtD
Capreomycin—Leukopenia—Etoposide—testicular cancer	0.00339	0.00339	CcSEcCtD
Capreomycin—Body temperature increased—Dactinomycin—testicular cancer	0.00337	0.00337	CcSEcCtD
Capreomycin—Hypersensitivity—Bleomycin—testicular cancer	0.00337	0.00337	CcSEcCtD
Capreomycin—Pain—Ifosfamide—testicular cancer	0.00334	0.00334	CcSEcCtD
Capreomycin—Thrombocytopenia—Cisplatin—testicular cancer	0.0033	0.0033	CcSEcCtD
Capreomycin—Eosinophilia—Methotrexate—testicular cancer	0.00322	0.00322	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—testicular cancer	0.0032	0.0032	CcSEcCtD
Capreomycin—Hypersensitivity—Dactinomycin—testicular cancer	0.00314	0.00314	CcSEcCtD
Capreomycin—Urticaria—Ifosfamide—testicular cancer	0.0031	0.0031	CcSEcCtD
Capreomycin—Body temperature increased—Ifosfamide—testicular cancer	0.00309	0.00309	CcSEcCtD
Capreomycin—Thrombocytopenia—Etoposide—testicular cancer	0.00302	0.00302	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—testicular cancer	0.00296	0.00296	CcSEcCtD
Capreomycin—Rash—Bleomycin—testicular cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Pain—Cisplatin—testicular cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Dermatitis—Bleomycin—testicular cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Hypersensitivity—Ifosfamide—testicular cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Renal failure—Methotrexate—testicular cancer	0.00285	0.00285	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—testicular cancer	0.00279	0.00279	CcSEcCtD
Capreomycin—Rash—Dactinomycin—testicular cancer	0.00269	0.00269	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Capreomycin—Body temperature increased—Cisplatin—testicular cancer	0.00266	0.00266	CcSEcCtD
Capreomycin—Pain—Etoposide—testicular cancer	0.00264	0.00264	CcSEcCtD
Capreomycin—Hypersensitivity—Cisplatin—testicular cancer	0.00248	0.00248	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Capreomycin—Rash—Ifosfamide—testicular cancer	0.00246	0.00246	CcSEcCtD
Capreomycin—Dermatitis—Ifosfamide—testicular cancer	0.00246	0.00246	CcSEcCtD
Capreomycin—Urticaria—Etoposide—testicular cancer	0.00245	0.00245	CcSEcCtD
Capreomycin—Body temperature increased—Etoposide—testicular cancer	0.00244	0.00244	CcSEcCtD
Capreomycin—Tinnitus—Methotrexate—testicular cancer	0.00243	0.00243	CcSEcCtD
Capreomycin—Hypersensitivity—Etoposide—testicular cancer	0.00227	0.00227	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Capreomycin—Rash—Cisplatin—testicular cancer	0.00212	0.00212	CcSEcCtD
Capreomycin—Dermatitis—Cisplatin—testicular cancer	0.00212	0.00212	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Capreomycin—Vertigo—Methotrexate—testicular cancer	0.00204	0.00204	CcSEcCtD
Capreomycin—Leukopenia—Methotrexate—testicular cancer	0.00203	0.00203	CcSEcCtD
Capreomycin—Rash—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Capreomycin—Dermatitis—Etoposide—testicular cancer	0.00194	0.00194	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Capreomycin—Thrombocytopenia—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—testicular cancer	0.00176	0.00176	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—testicular cancer	0.00176	0.00176	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Capreomycin—Pain—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Capreomycin—Pain—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Capreomycin—Urticaria—Methotrexate—testicular cancer	0.00147	0.00147	CcSEcCtD
Capreomycin—Body temperature increased—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Pain—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Hypersensitivity—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Capreomycin—Rash—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Capreomycin—Dermatitis—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Capreomycin—Rash—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Capreomycin—Rash—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
